MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

$17.73 +1.46%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-06 APPROXIMATE

Across 13 earnings reports since Mar 20, 2023, MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) has a clear post-earnings pattern. It moves ±4.26% on average after reporting and finishes higher 46.2% of the time. Its largest post-earnings gain was +10.69% (May 11, 2026) and its largest decline was -15.02% (Feb 29, 2024). The next earnings report is predicted for 2026-08-06 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.26%

Positive %

46.2%

Negative %

53.8%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 11, 2026	☀ PRE	$18.41	$20.88	$18.85	152,963	+10.69%	open_in_new
Feb 23, 2026	☀ PRE	$18.28	$19.48	$18.70	122,491	-0.53%	open_in_new
Nov 05, 2025	☀ PRE	$10.59	$10.72	$10.60	96,307	+4.59%	open_in_new
Aug 05, 2025	☀ PRE	$53.06	$53.50	$53.42	20,306	+0.05%	open_in_new
May 12, 2025	☽ POST	$39.65	$40.66	$40.24	13,596	-3.95%	open_in_new
Feb 26, 2025	☀ PRE	$40.69	$42.91	$42.35	25,433	+3.88%	open_in_new
Nov 07, 2024	☀ PRE	$52.00	$52.00	$50.60	19,766	-1.99%	open_in_new
Aug 07, 2024	☀ PRE	$43.50	$44.52	$43.01	15,661	-2.06%	open_in_new
May 07, 2024	☀ PRE	$43.44	$44.14	$43.64	13,256	-1.95%	open_in_new
Feb 29, 2024	☀ PRE	$56.39	$56.43	$48.24	93,049	-15.02%	open_in_new
Nov 14, 2023	☀ PRE	$37.23	$37.98	$37.40	64,364	+1.82%	open_in_new
Aug 10, 2023	☀ PRE	$54.15	$56.10	$54.44	54,583	+0.31%	open_in_new
Mar 20, 2023	☀ PRE	$21.77	$21.85	$21.21	96,754	-8.48%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.26%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

4 most recent

Form	Date Filed	View on EDGAR
8-K	20260609	open_in_new SEC.gov
8-K	20260601	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
4	20260513	open_in_new SEC.gov

Frequently asked about MLTX earnings

When does MoonLake Immunotherapeutics Class A Ordinary Shares report earnings next? expand_more

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MLTX stock move after earnings? expand_more

Over 13 reports, MLTX has moved an average of ±4.26% the session after earnings, closing higher 46.2% of the time.

What was MLTX's biggest post-earnings move? expand_more

MLTX's largest post-earnings gain on record was +10.69% on May 11, 2026, and its largest decline was -15.02% on Feb 29, 2024.

Where can I find MoonLake Immunotherapeutics Class A Ordinary Shares's SEC filings? expand_more

All of MoonLake Immunotherapeutics Class A Ordinary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.